Efficacy and pharmacokinetics of a new controlled-release morphine sulfate 200-mg tablet

Hanks, G. W., Hanna, M., Finlay, Ilora Gillian, Radstone, D. J. and Keeble, T. 1995. Efficacy and pharmacokinetics of a new controlled-release morphine sulfate 200-mg tablet. Journal of Pain and Symptom Management 10 (1) , pp. 6-12. 10.1016/0885-3924(94)00067-u

Full text not available from this repository.

Abstract

Nineteen of 25 patients (14 female) with advanced malignant disease completed a randomized controlled trial of a new high-dose (200 mg) tablet formulation of controlled-release morphine. Compared with the currently available 100-mg tablets there were no differences in pain severity or adverse effects with the new formulation. In four patients, full 12-hr plasma morphine concentration profiles at steady state were obtained and showed no significant differences between the same dose provided as 100-mg and 200-mg tablets in Cmax, tmax, or other pharmacokinetic indices.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > R Medicine (General) R Medicine > RZ Other systems of medicine
Publisher:	Elsevier
ISSN:	0885-3924
Last Modified:	04 Jun 2017 07:47
URI:	https://orca.cardiff.ac.uk/id/eprint/68003

Citation Data

Cited 18 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item